RANEPHRINE Trademark

Trademark Overview


On Monday, September 18, 1961, a trademark application was filed for RANEPHRINE with the United States Patent and Trademark Office. The USPTO has given the RANEPHRINE trademark a serial number of 72128083. The federal status of this trademark filing is EXPIRED as of Tuesday, August 11, 1987. This trademark is owned by PASCAL COMPANY, INC.. The RANEPHRINE trademark is filed in the Pharmaceutical Products category with the following description:

EPINEPHRINE SOLUTION FOR TOPICAL USE AS A DENTAL HEMOSTAT AND RETRACTION OF TISSUE AND OTHER SIMILAR USES IN CONNECTION WITH DENTAL OPERATIONS

General Information


Serial Number72128083
Word MarkRANEPHRINE
Filing DateMonday, September 18, 1961
Status900 - EXPIRED
Status DateTuesday, August 11, 1987
Registration Number0732093
Registration DateTuesday, May 29, 1962
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE
Attorney NameNOT AVAILABLE
Law Office Location Code000
Employee NameNOT AVAILABLE
CorrespondentNOT AVAILABLE

Trademark Statements


Goods and ServicesEPINEPHRINE SOLUTION FOR TOPICAL USE AS A DENTAL HEMOSTAT AND RETRACTION OF TISSUE AND OTHER SIMILAR USES IN CONNECTION WITH DENTAL OPERATIONS

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes018
Class Status Code9 - Expired
Class Status DateTuesday, August 11, 1987
Primary Code018
First Use Anywhere DateTuesday, August 8, 1961
First Use In Commerce DateTuesday, August 8, 1961

Trademark Owner History


Party NamePASCAL COMPANY, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
Address231 DEXTER AVE.
SEATTLE, WA

Trademark Events


Event DateEvent Description
Tuesday, August 11, 1987EXPIRED SEC. 9